According to reports, a cause for concern is that 51 of the cases involve infants under one year of age, while 553 are among children under 18.

Valneva SE offers exposure to a robust travel vaccine portfolio that includes Ixiaro, Dukoral, and Ixchiq. Read what ...

Chandigarh: Amid a steady rise in dengue and chikungunya cases across the state, the Punjab health department directed all ...

Valneva (VALN) stock slips as the EU drug regulator suspends chikungunya vaccine for adults 65+ over safety concerns. Read ...

The decision was taken following a plenary meeting of the Pharmacovigilance Risk Assessment Committee (PRAC) on May 5, 2025 and is based on reports of 17 SAEs worldwide (including two deaths) in ...

The European Union's health regulator said on Wednesday it was reviewing French drugmaker Valneva's chikungunya vaccine after ...